These results indicate that ADAM9-abundant medium or plasminogen activator-based pathway served as a causative contributor to endothelial cell breakdown and suggest that ANGPT2 and PLAT regulated by ADAM9 from brain-metastatic lung cancer cells disrupts HBMEC integrity. This evidence concerns the gene ADAM9 and lung carcinoma.